ZGI 04
Latest Information Update: 14 Feb 2006
Price :
$50 *
At a glance
- Originator ZymoGenetics
- Class Anti-ischaemics
- Mechanism of Action Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myocardial ischaemia
Most Recent Events
- 14 Feb 2006 No development reported - Preclinical for Myocardial ischaemia in USA (unspecified route)
- 23 Sep 2002 This compound is still in active development
- 30 Nov 2000 New profile